Events

SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, today announced...

ImmunoScape Leadership to Present at Upcoming Industry Conferences CEO Choon-Peng Ng and Vice President of Innovation, Michael Fehlings, Ph.D., will discuss Asia’s role...

The ImmunoScape team is heading to the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco in a few weeks. Our CEO Choon-Peng (Choon) Ng, our Vice President,...

Florian Schmidt, PhD will be presenting at the upcoming ISMB/ECCB 2023 conference in Lyon. On Thursday, July 27th Florian will describe ImmunoScape’s machine learning...

Our team is headed to #bio2023 in Boston June 5-8! Our CEO Choon-Peng (Choon) Ng and our Senior Director, Business Development Christopher Alfonso will be on site at...